NASDAQ · Medical - Diagnostics & Research

RDNT (RDNT) Stock

$70.43 +3.33% NASDAQ: RDNT Healthcare

Valuation

MetricValue
Price$70.43
Market Cap$5.54B
P/E Ratio54.55
P/B Ratio3.98
P/S Ratio2.04
EPS (TTM)$-0.17
52-Week High$85.84
52-Week Low$50.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE1.77%
ROA1.53%
ROCE6.71%
Gross Margin17.07%
Operating Margin-3.45%
Net Margin-0.66%
Debt/Equity1.79
Current Ratio1.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.3B$1.4B$1.6B$1.8B$2.0B
Operating Profit$83.0M$46.0M$99.0M$105.0M$91.0M
Net Profit$25.0M$11.0M$3.0M$3.0M$-19.0M
EPS$0.46$0.17$0.05$0.04$-0.25
Op Margin6.3%3.2%6.1%5.7%4.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.1B$2.4B$2.7B$3.3B$3.8B
Total Liabilities$1.7B$1.9B$1.9B$2.2B$2.4B
Cash$135.0M$128.0M$343.0M$740.0M$767.0M
Borrowings$1.4B$1.5B$1.5B$1.7B$1.9B

Latest News

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call GlobeNewswire · Jul 22, 2026 RDNT: Lowering target price to $59.00 Argus Research · Jul 22, 2026 3 Cash-Burning Stocks with Open Questions StockStory · Jul 21, 2026 How RadNet’s (RDNT) AI Reporting Tools Could Improve Imaging Center Scale and Workflow Insider Monkey · Jul 7, 2026 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT Newswires · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$149.0M$146.0M$221.0M$233.0M$299.0M
Investing Cash Flow$-442.0M$-496.0M$-378.0M$-421.0M$-557.0M
Financing Cash Flow$10.0M$-1.0M$-6.0M$14.0M$-4.0M
Net Cash Flow$33.0M$-7.0M$215.0M$397.0M$27.0M
Free Cash Flow$-71.0M$-103.0M$44.0M$45.0M$86.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.96
EV / EBITDA24.59
FCF Yield-3.39%
Quick Ratio1.17
Interest Coverage1.30
Return 1Y6.78%
Return 3Y76.82%
Return 5Y84.69%

Ownership

Insiders Held9.97%
Institutions Held100.65%
Institutions Float Held111.79%
Institutional HolderSharesReport Date
Blackrock Inc.10,035,7342026-03-31
RTW Investments LP4,285,0002026-03-31
Price (T.Rowe) Associates Inc4,154,8632026-03-31
Vanguard Portfolio Management LLC3,899,1272026-03-31
Beck, Mack & Oliver LLC3,166,1922026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLCO $16.76 +0.48% 13.97 $5.99B 0.00%
BRKR $62.91 +4.76% 23.24 $9.58B 0.35%
BTSGBrightSpring Health Services, Inc. Common Stock $71.98 -1.28% 89.58 $14.13B 0.00%
CHE $534.79 -0.85% 23.91 $7.10B 0.52%
IRTC $112.15 +2.70% 113.40 $3.69B 0.00%

About RDNT

RDNT stock trades at $70.43 with a market capitalization of $5.54B. The stock is valued at a price-to-earnings (P/E) ratio of 54.55, price-to-book of 3.98, price-to-sales of 2.04. Over the past 52 weeks the stock has ranged between $50.76 and $85.84, and currently trades 18.0% below its 52-week high.

On profitability, RDNT generates a return on equity (ROE) of 1.77%, return on capital employed of 6.71%, an operating margin of -3.45%, a net profit margin of -0.66%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides